Chen Xin Pharmaceutical announced that the company's “BFS 'blow and sealing' integrated aseptic filling production line project” has been implemented and completed. As of August 12, 2026, the remaining balance of the project was 13.095 million yuan, and subsequent related final payments and guarantees will be paid with its own funds. The company plans to permanently supplement the remaining balance of the above working capital to improve the efficiency of the use of funds raised and reduce financial expenses. The final amount is based on the amount at the time the bank account is cancelled. The matter has been reviewed and approved by the 14th meeting of the 5th board of directors of the company and will be submitted to the first extraordinary shareholders' meeting in 2026 for review.

Chen Xin Pharmaceutical announced that the company's “BFS 'blow and sealing' integrated aseptic filling production line project” has been implemented and completed. As of August 12, 2026, the remaining balance of the project was 13.095 million yuan, and subsequent related final payments and guarantees will be paid with its own funds. The company plans to permanently supplement the remaining balance of the above working capital to improve the efficiency of the use of funds raised and reduce financial expenses. The final amount is based on the amount at the time the bank account is cancelled. The matter has been reviewed and approved by the 14th meeting of the 5th board of directors of the company and will be submitted to the first extraordinary shareholders' meeting in 2026 for review.